Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-49,921
Closed -$22.6K 5999
2025
Q2
$22.6K Sell
49,921
-11,034
-18% -$4.8K ﹤0.01% 5456
2025
Q1
$24.8K Buy
60,955
+32,603
+115% +$20.9K ﹤0.01% 5235
2024
Q4
$18.8K Sell
28,352
-30,607
-52% -$21.3K ﹤0.01% 5207
2024
Q3
$50.1K Buy
58,959
+46,252
+364% +$35.4K ﹤0.01% 4997
2024
Q2
$8.48K Buy
12,707
+1,799
+16% +$1.49K ﹤0.01% 4981
2024
Q1
$14.2K Sell
10,908
-11,202
-51% -$11.7K ﹤0.01% 4871
2023
Q4
$12.7K Sell
22,110
-1,266
-5% -$875 ﹤0.01% 4754
2023
Q3
$17.6K Sell
23,376
-3,549
-13% -$2.7K ﹤0.01% 4616
2023
Q2
$19.7K Buy
26,925
+2,012
+8% +$1.87K ﹤0.01% 4519
2023
Q1
$18.9K Sell
24,913
-1,812
-7% -$1.68K ﹤0.01% 4414
2022
Q4
$25.7K Sell
26,725
-4,000
-13% -$5.65K ﹤0.01% 4342
2022
Q3
$67K Sell
30,725
-139,400
-82% -$481K ﹤0.01% 4189
2022
Q2
$595K Buy
170,125
+19,935
+13% +$74.5K ﹤0.01% 3066
2022
Q1
$757K Buy
150,190
+9,061
+6% +$45.9K ﹤0.01% 2845
2021
Q4
$885K Buy
141,129
+61,557
+77% +$420K ﹤0.01% 2763
2021
Q3
$633K Buy
79,572
+40,786
+105% +$336K ﹤0.01% 3007
2021
Q2
$291K Buy
38,786
+17,888
+86% +$125K ﹤0.01% 3610
2021
Q1
$126K Sell
20,898
-21,656
-51% -$167K ﹤0.01% 3881
2020
Q4
$243K Buy
42,554
+5,980
+16% +$38K ﹤0.01% 3370
2020
Q3
$243K Buy
+36,574
New +$326K ﹤0.01% 3059

Other funds holding VXRT

LPL Financial's VXRT Position: Q3 2025 in Review

LPL Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 49,921 shares — an estimated $22.6K sold.

LPL Financial first reported a position in VXRT in Q3 2020 and held it in 20 quarters. The position peaked at $885K in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • LPL Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 49,921 Vaxart shares in Q3 2025, an estimated $22.6K.
  • LPL Financial first reported a position in Vaxart in Q3 2020 and held it in 20 quarters.
  • LPL Financial's Vaxart position peaked at $885K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.